Intuitive Surgical, Inc.
General ticker "ISRG" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $192.2B
Intuitive Surgical, Inc. follows the US Stock Market performance with the rate: 72.6%.
Estimated limits based on current volatility of 1.3%: low 522.30$, high 536.59$
Factors to consider:
- Company included in S&P500 list
- Current price 18.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [312.44$, 443.82$]
- 2024-12-30 to 2025-12-30 estimated range: [361.43$, 502.75$]
Financial Metrics affecting the ISRG estimates:
- Positive: Non-GAAP EPS, $ of 5.71 > 2.29
- Negative: Operating cash flow per share per price, % of 1.61 <= 2.35
- Positive: Operating profit margin, % of 24.80 > 19.51
- Positive: Return on assets ratio (scaled to [-100,100]) of 10.53 > 7.10
- Positive: -3.48 < Investing cash flow per share, $ of -1.03
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term ISRG quotes
Long-term ISRG plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $5,710.10MM | $6,222.20MM | $7,124.10MM |
| Operating Expenses | $3,889.10MM | $4,645.10MM | $5,357.30MM |
| Operating Income | $1,821.00MM | $1,577.10MM | $1,766.80MM |
| Non-Operating Income | $69.30MM | $29.70MM | $192.10MM |
| Interest Expense | $0.00MM | $29.70MM | $0.00MM |
| R&D Expense | $671.00MM | $879.00MM | $998.80MM |
| Income(Loss) | $1,890.30MM | $1,606.80MM | $1,958.90MM |
| Taxes | $162.20MM | $262.40MM | $141.60MM |
| Profit(Loss) | $1,728.10MM | $1,344.40MM | $1,817.30MM |
| Stockholders Equity | $11,901.10MM | $11,041.90MM | $13,307.60MM |
| Inventory | $587.10MM | $893.20MM | $1,220.60MM |
| Assets | $13,555.00MM | $12,974.00MM | $15,441.50MM |
| Operating Cash Flow | $2,089.40MM | $1,490.80MM | $1,813.80MM |
| Capital expenditure | $353.50MM | $532.40MM | $1,064.20MM |
| Investing Cash Flow | $-2,461.50MM | $1,370.80MM | $-360.10MM |
| Financing Cash Flow | $43.00MM | $-2,572.30MM | $-287.60MM |
| Earnings Per Share* | $4.79 | $3.72 | $5.12 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.